Abstract:Proteins have proven to be useful agents in a variety of fields, from serving as potent therapeutics to enabling complex catalysis for chemical manufacture. However, they remain difficult to design and are instead typically selected for using extensive screens or directed evolution. Recent developments in protein large language models have enabled fast generation of diverse protein sequences in unexplored regions of protein space predicted to fold into varied structures, bind relevant targets, and catalyze novel reactions. Nevertheless, we lack methods to characterize these proteins experimentally at scale and update generative models based on those results. We describe Protein CREATE (Computational Redesign via an Experiment-Augmented Training Engine), an integrated computational and experimental pipeline that incorporates an experimental workflow leveraging next generation sequencing and phage display with single-molecule readouts to collect vast amounts of quantitative binding data for updating protein large language models. We use Protein CREATE to generate and assay thousands of designed binders to IL-7 receptor α and insulin receptor with parallel positive and negative selections to identify on-target binders. We discover not only individual novel binders but also features of ligand-receptor binding, including preservation of the IL7Rα - ligand hydrophobic interface specifically and existence of multiple approaches to contact the insulin receptor. We also demonstrate the importance of structural features, such as the lack of unpaired cysteine residues, toward design fidelity and find computational pre-screening metrics, such as interchain predicted TM scoring (iPTM), while useful, are imperfect predictors as they neither guarantee experimental binding nor rule it out. We use the data collected from Protein CREATE to score designs from the initial generative models. Globally, Protein CREATE will power future closed-loop design-build-test cycles to enable fine-grained design of protein binders.

Computational Design Of Ligand-Binding Proteins

Computational Design of Proteins with Novel Structure and Functions

Combined and Iterative Use of Computational Design and Directed Evolution for Protein-Ligand Binding Design

De novo design of drug-binding proteins with predictable binding energy and specificity

[Computational chemistry in structure-based drug design].

Computer Modeling for Interaction of Ligands and Receptors and Their Applications in Drug Design

Towards Structure-Based Protein Drug Design

Computational Protein Design - Where It Goes?

New trends in computational structure prediction of ligand-protein complexes for receptor-based drug design

Design of High Affinity Binders to Convex Protein Target Sites

Design of Ligand-Binding Proteins with Atomic Flow Matching

Maßgeschneiderte Liganden für Protein-Protein-Interaktionen

Coupling Protein Side-Chain and Backbone Flexibility Improves the Re-design of Protein-Ligand Specificity

Computational Peptidology: A New and Promising Approach to Therapeutic Peptide Design

Protein-protein interface analysis and hot spots identification for chemical ligand design.

Computational Protein Design with Data‐driven Approaches: Recent Developments and Perspectives

Robust de novo design of protein binding proteins from target structural information alone

Protein CREATE enables closed-loop design of de novo synthetic protein binders

LigBuilder 2: A Practical De Novo Drug Design Approach

Computational Methods-Guided Design of Modulators Targeting Protein-Protein Interactions (Ppis)

COMPUTATIONAL METHOD FOR DRUG TARGET SEARCH AND APPLICATION IN DRUG DISCOVERY